Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-27 · accession 0001209191-23-014275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-03-01 | 2023-02-27 | ARWR | GIVEN DOUGLAS B | Dir | S - Sale | $32.62 | -875 | 13.0K | -6% | -$28.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | S | D | 875 | $32.62 | 13,000 | I By Trust | — | — | (F1) Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust. |